Scholarlink

Backgrounds <p>Fournier’s gangrene is a life-threatening condition. To predict patient outcomes, it requires a thorough understanding of the variables influencing the severity of this illness and the emergence of comorbidities. </p> Aims <p>To evaluate the Comprehensive complication index score to predict postoperative mortality in Fournier gangrene. </p> Methods <p>Between 2013 and 2024, a retrospective analysis was used to identify patients who were diagnosed with Fournier’s gangrene. The perioperative and clinical data were recorded. Postoperative complications were assessed using the Clavien-Dindo classification (CDC). The Comprehensive Complication index was calculated based on CDC and when multiple complications occurred, their values were combined using the CCI formula to generate a cumulative score for each patient. Upgrading was interpreted as a CCI cumulative score surpasses the baseline score. The data was divided into two groups based on patients’ mortality outcome; group 1: survive group, group 2: mortality group</p> Results <p>The age and comorbidities were significantly higher in group 2, (p&lt;0.001 and p=0.015). The frequency of sepsis was considerably higher in group 2 patients (p&lt;0.001). The CCI score significantly higher in group 2 (p&lt;0.001). ROC analysis showed that the CCI score greater than 36.60 could accurately predict mortality with high specificity and sensitivity (91.3% and 70.0%, respectively). Multivariate analysis identified both fage (OR: 1.436, p = 0.002) and CCI score (OR: 1.093, p = 0.008) as independent predictors of mortality.</p> Conclusion <p>The CCI is a useful instrument for evaluating cumulative postoperative morbidity and forecasting mortality in patients with Fournier’s gangrene. Incorporating the CCI into clinical practice may enhance risk classification, optimize resource allocation, and inform treatment decision-making in FG management.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Development and validation of a comprehensive complication index for predicting outcomes in fournier’s gangrene

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月29日

查看全文
  • Fatih Gokalp,
  • Eser Ordek,
  • Muhanned Sammala,
  • Duran Kuru,
  • Ferhat Ucurmak,
  • Sadik Gorur

摘要

Backgrounds

Fournier’s gangrene is a life-threatening condition. To predict patient outcomes, it requires a thorough understanding of the variables influencing the severity of this illness and the emergence of comorbidities.

Aims

To evaluate the Comprehensive complication index score to predict postoperative mortality in Fournier gangrene.

Methods

Between 2013 and 2024, a retrospective analysis was used to identify patients who were diagnosed with Fournier’s gangrene. The perioperative and clinical data were recorded. Postoperative complications were assessed using the Clavien-Dindo classification (CDC). The Comprehensive Complication index was calculated based on CDC and when multiple complications occurred, their values were combined using the CCI formula to generate a cumulative score for each patient. Upgrading was interpreted as a CCI cumulative score surpasses the baseline score. The data was divided into two groups based on patients’ mortality outcome; group 1: survive group, group 2: mortality group

Results

The age and comorbidities were significantly higher in group 2, (p<0.001 and p=0.015). The frequency of sepsis was considerably higher in group 2 patients (p<0.001). The CCI score significantly higher in group 2 (p<0.001). ROC analysis showed that the CCI score greater than 36.60 could accurately predict mortality with high specificity and sensitivity (91.3% and 70.0%, respectively). Multivariate analysis identified both fage (OR: 1.436, p = 0.002) and CCI score (OR: 1.093, p = 0.008) as independent predictors of mortality.

Conclusion

The CCI is a useful instrument for evaluating cumulative postoperative morbidity and forecasting mortality in patients with Fournier’s gangrene. Incorporating the CCI into clinical practice may enhance risk classification, optimize resource allocation, and inform treatment decision-making in FG management.